AlphaVax

About:

AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer.

Description:

AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.

Total Funding Amount:

$48.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

1997-01-01

Contact Email:

finance(AT)alphavax.com

Founders:

Jonathan F. Smith, Nancy Davis, Robert Johnston

Number of Employees:

51-100

Last Funding Date:

2007-02-05

IPO Status:

Private

Industries: